Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to find out how effective low dose oral naltrexone is
on reducing body weight when compared to placebo in women with schizophrenia and
schizoaffective disorder.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Collaborator:
Ethel F. Donaghue Women's Health Investigator Program at Yale